The over-arching goal of the UT Houston Substance Abuse Research-Medication Development Center is to develop safe, effective medications for cocaine dependence. The current Center proposal focuses on elucidating behavioral and neurochemical mechanisms of cocaine dependence and using these findings to guide clinical trials for promising medications. The Advanced Clinical Design and Statistical Analysis Core (ACDSAC) will serve as a critical mechanism for promoting this goal by providing statistical/methodological support for NIDA-funded clinical trials in drug dependence taking place at University of Texas Health Science Center at Houston-Medication Development Center as well as consultation to other NIDA-funded centers. The ACDSAC will accomplish this by: 1) providing support for the design and analysis of conventional clinical trials; 2) advancing utilization of flexible/adaptive study designs for the development of more efficient clinical trials; 3) advancing statistical methodologies for the analysis of clinical trials with a focus on Bayesian modeling and the use of structural equation modeling methodologies for evaluation of mediational hypotheses of drug action. 4) serving as a liaison to the statistical and design divisions of the Center for Clinical Research and Evidence-Based Medicine as well as the Center for Clinical Translational Science, both of the University of Texas Health Science Center at Houston; 5) providing training to post-doctoral staff, fellows and students in study design and advanced quantitative methods; The Advanced Clinical Design and Statistical Analysis Core will advance the overall goal of the UT Houston Medication Development Center by providing advanced novel statistical design and analysis support for medication development clinical trials.
The dearth of acceptable and effective treatments for substance dependence coupled with the heterogeneous nature of the patient population and the accruing wealth of neurobiological evidence concerning this problem argue that innovative design and analyses should be implemented to maximize the likelihood of identifying successful treatments in the most efficient way possible.
|Lindsay, Jan A; Minard, Charles G; Hudson, Sonora et al. (2014) Using prize-based incentives to enhance daily interactive voice response (IVR) compliance: a feasibility study. J Subst Abuse Treat 46:74-7|
|Sharma, Jyoti; Rathnayaka, Nuvan; Green, Charles et al. (2014) Bradycardia as a Marker of Chronic Cocaine Use: A Novel Cardiovascular Finding. Behav Med :1-8|
|Schmitz, Joy M; Green, Charles E; Stotts, Angela L et al. (2014) A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone. Drug Alcohol Depend 136:100-7|
|Narayana, Ponnada A; Herrera, Juan J; Bockhorst, Kurt H et al. (2014) Chronic cocaine administration causes extensive white matter damage in brain: diffusion tensor imaging and immunohistochemistry studies. Psychiatry Res 221:220-30|
|Farris, Samantha G; Zvolensky, Michael J; Beckham, Jean C et al. (2014) Trauma exposure and cigarette smoking: the impact of negative affect and affect-regulatory smoking motives. J Addict Dis 33:354-65|
|Hasan, Khader M; Moeller, F Gerard; Narayana, Ponnada A (2014) DTI-based segmentation and quantification of human brain lateral ventricular CSF volumetry and mean diffusivity: validation, age, gender effects and biophysical implications. Magn Reson Imaging 32:405-12|
|Fineberg, Naomi A; Chamberlain, Samuel R; Goudriaan, Anna E et al. (2014) New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity. CNS Spectr 19:69-89|
|Lane, Scott D; Green, Charles E; Schmitz, Joy M et al. (2014) Comparison of Caffeine and d-amphetamine in Cocaine-Dependent Subjects: Differential Outcomes on Subjective and Cardiovascular Effects, Reward Learning, and Salivary Paraxanthine. J Addict Res Ther 5:176|
|Liu, Shijing; Green, Charles E; Lane, Scott D et al. (2014) The influence of dopamine ?-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study. Pharmacogenet Genomics 24:370-3|
|Anastasio, N C; Liu, S; Maili, L et al. (2014) Variation within the serotonin (5-HT) 5-HT?C receptor system aligns with vulnerability to cocaine cue reactivity. Transl Psychiatry 4:e369|
Showing the most recent 10 out of 55 publications